Monster Beverage heads into its August 6 earnings with analyst sentiment nudging higher, options positioning its least defensive in months, and borrow conditions that give bears virtually nothing to work with.
The clearest catalyst this week came from the Street. Wells Fargo lifted its target from $97 to $105 on July 8, maintaining its Overweight rating — a meaningful move that pushes the stock back above its mean analyst price target of $90. That divergence is worth noting: MNST closed Tuesday at $96.92, already above the consensus target, meaning the Wells Fargo raise is less a discovery call and more an acknowledgment that the market has re-rated the name. Morgan Stanley had moved in the same direction in June, raising to $103, while Bernstein's fresh initiation at Market Perform with a $95 target sits below the current price — a mild brake on the bullish momentum. The picture is one of incremental upgrades rather than a wholesale re-rating, with bulls pointing to international expansion and the Coca-Cola distribution partnership, while bears flag the risk of a growth plateau and margin compression after a strong run.
Options positioning supports the more constructive mood. The put/call ratio has quietly dropped to its lowest level of the past year, now running at 0.90 against a 20-day average near 1.00. That shift is striking in context: through most of May and into June, the PCR was holding above 1.10, reflecting genuine hedging demand. The move below 0.90 — near the 52-week low of 0.80 — signals that options traders have rotated away from downside protection and toward more directional positioning. The z-score of -0.64 confirms this is a meaningful departure from the recent norm, not a one-day quirk.
Short interest tells a straightforward story: there is very little of it. Bears hold roughly 2.2% of the free float short, a figure that drifted up about 10% over the past month but ticked back down 1.3% on the week to around 22 million shares. The borrow market is wide open — availability is running above 6,800%, meaning the lending pool dwarfs the existing short position by an enormous margin. Cost to borrow has fallen roughly 35% on the week to just 0.24%, its lowest level in at least six weeks. There is no squeeze dynamic here, no tight borrow, and no aggressive short rebuild — this is a stock where bears can express a view cheaply and easily, and most are choosing not to.
The one note of caution sits in the recent insider activity. The Chief Commercial Officer sold nearly $8.5 million worth of shares across two tranches in May, the CFO sold $615,000, and a director sold $4.6 million — all at prices around $85-88, well below today's level. A division CEO added a further $1.7 million sale in June at $90.90. The 90-day net insider transaction value is technically positive at around $44 million, but the bulk of that figure reflects share awards at zero cost, not open-market purchases. The read from the insider table is one of consistent selling into strength, not accumulation.
On valuation, the stock trades at 38.9x trailing earnings and 28.8x EV/EBITDA — multiples that have risen about 8% and 1% respectively over the past 30 days as the stock climbed 8.2% on the month. Among peers, KO gained 1.7% on the week and CELH surged 6.4%, while KDP shed 6% — MNST's 0.8% weekly gain sits in the middle of a scattered peer group. The ORTEX short score of 36 and factor scores — with days-to-cover ranking in the 66th percentile and EPS surprise in the 71st — suggest a stock that beats estimates more often than not but carries no particular squeeze setup heading into August 6.
The key question into that August print is whether Monster can show international volume momentum convincing enough to justify a price that has now run above most analyst targets.
See the live data behind this article on ORTEX.
Open MNST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
